Wang Xin, Zheng Lie, Zhang Shi-Yi, Xie Ze-Ming, Yu Hui, Su Xiao-Dong, Wang Jun-Ye, Huang Zhi-Fan, Yang Ming-Tian, Rong Tie-Hua
Department of Thoracic Surgery, Sun Yet-sen University Cancer Center, Guangzhou 510060, China.
Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):456-9.
To discuss the strategy of mediastinoscopy for the evaluation of mediastinal lymph node status (metastasis or not) of non-small cell lung cancer (NSCLC) prior to surgery.
From October 2000 to June 2007, 152 consecutive NSCLC cases pathologically proven and clinically staged I-III were enrolled in the study. Of the 152 cases, there were 118 males and 34 females. Age ranged 24-79 years old and the median age was 58. All cases underwent CT and mediastinoscopy for the evaluation of mediastinal lymph node status prior to surgery. Compared with the results of final pathology, the positive rate of mediastinoscopy and the prevalence of mediastinal lymph node metastasis were calculated in the NSCLC patients with negative mediastinal or hilar lymph nodes on CT scan (the shortest axis of mediastinal or hilar lymph nodes <1 cm). Clinical characteristics used as predictive factor including sex, age, cancer location, type of pathology, T status, cancer type (central or peripheral), size of mediastinal lymph nodes (the shortest axis <1 cm or >1 cm) on CT scan and serum CEA level were analyzed by univariate and multivariate analysis with Binary logistic regression model to identify risk factors of mediastinal metastasis.
The positive rate of mediastinoscopy was 11.6% (8/69) and the prevalence of mediastinal metastasis was 20.1% (14/69) in NSCLC with negative mediastinal or hilar lymph nodes on CT scan respectively. In clinical stage I (cT1-2N0M0) NSCLC the positive rate of mediastinoscopy was 11.3% (7/62), N2 accounting for 6.5% (4/62) and N3 4.8% (3/62), respectively; and the prevalence of mediastinal lymph node metastasis was 19.4% (12/62), N2 ccounting for 14.6% (9/62) and N3 4.8% (3/62), respectively. In the whole group both univariate and multivariate analysis showed that adenocarcinoma or mediastinal lymph nodes > or =1 cm in the shortest axis on CT scan was an independent risk factor to predict mediastinal lymph node metastasis. In NSCLC with negative mediastinal or hilar lymph nodes on CT scan both univariate and multivariate analysis showed that adenocarcinoma was a predictor of mediastinal lymph node metastasis. Conclusion We recommend the policy of routine mediastinoscopy in NSCLC prior to surgery if the mediastinal staging was only based on CT scan. Mediastinal lymph nodes > or =1 cm in the shortest axis on CT scan mandates preoperative mediastinoscopy. Adenocarcinoma also indicates mandatory mediastinoscopy even with negative mediastinal or hilar lymph nodes on CT scan.
探讨在非小细胞肺癌(NSCLC)手术前,运用纵隔镜检查评估纵隔淋巴结状态(有无转移)的策略。
选取2000年10月至2007年6月期间,152例经病理证实且临床分期为Ⅰ-Ⅲ期的连续NSCLC病例纳入研究。152例中,男性118例,女性34例。年龄范围为24-79岁,中位年龄为58岁。所有病例在手术前行CT及纵隔镜检查以评估纵隔淋巴结状态。将CT扫描显示纵隔或肺门淋巴结阴性(纵隔或肺门淋巴结短轴<1 cm)的NSCLC患者的纵隔镜检查阳性率及纵隔淋巴结转移率与最终病理结果进行比较。将性别、年龄、肿瘤位置、病理类型、T分期、肿瘤类型(中央型或周围型)、CT扫描显示的纵隔淋巴结大小(短轴<1 cm或>1 cm)及血清癌胚抗原水平等临床特征作为预测因素,采用二元逻辑回归模型进行单因素及多因素分析,以确定纵隔转移的危险因素。
CT扫描显示纵隔或肺门淋巴结阴性的NSCLC患者中,纵隔镜检查阳性率为11.6%(8/69),纵隔转移率为20.1%(14/69)。在临床Ⅰ期(cT1-2N0M0)NSCLC中,纵隔镜检查阳性率为11.3%(7/62),N2占6.5%(4/62),N3占4.8%(3/62);纵隔淋巴结转移率为19.4%(12/62),N2占14.6%(9/62),N3占4.8%(3/62)。在全组中,单因素及多因素分析均显示腺癌或CT扫描显示纵隔淋巴结短轴≥1 cm是预测纵隔淋巴结转移的独立危险因素。在CT扫描显示纵隔或肺门淋巴结阴性的NSCLC中,单因素及多因素分析均显示腺癌是纵隔淋巴结转移的预测因素。结论:如果纵隔分期仅基于CT扫描,我们建议NSCLC手术前常规行纵隔镜检查。CT扫描显示纵隔淋巴结短轴≥1 cm者术前需行纵隔镜检查。即使CT扫描显示纵隔或肺门淋巴结阴性,腺癌也提示必须行纵隔镜检查。